OncoStrands is a set of advanced genomic testing panels designed to analyse cancer-related genes through next-generation sequencing (NGS). These tests help clinicians identify genetic mutations, fusions, and other alterations that may drive cancer development, guiding personalized treatment strategies. The tests also help identify biomarkers for prognosis and potential participation in clinical trials.